NCT03780283 2018-12-21
Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC
First Hospital of Shijiazhuang City
Phase 2 Unknown
Clinical Trials
3 trialsNCT03765775 2018-12-06
Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative
First Hospital of Shijiazhuang City
Phase 2 Unknown
NCT03589950 2018-07-18
Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer
The First People's Hospital of Lianyungang
Phase 2 Unknown